Factors associated with non-adherence to leprosy multidrug therapy: a review
Leprosy is one of the oldest diseases that affect man. With the emergence of multidrug therapy, usually consisting of dapsone, clofazimine and rifampicin, there has been a significant decline in the prevalence of leprosy worldwide. However, developing countries such as Brazil have struggled to achieve the elimination goals proposed by the World Health Organization. According to the literature, late diagnosis and non-adherence to treatment have been associated with this failure.